Gaps Persist in Actual Versus Optimal Atherosclerotic Cardiovascular Disease Care

Follow Drugslib on

Medically reviewed by Melisa Puckey, BPharm. Last updated on Dec 5, 2023.

By Lori Solomon HealthDay Reporter

TUESDAY, Dec. 5, 2023 -- Roughly half of patients with atherosclerotic cardiovascular disease (ASCVD) adopt optimal prevention strategies across racial and ethnic subgroups, according to a study published online Dec. 1 in JAMA Network Open.

Yuan Lu, Sc.D., from Yale New Haven Hospital in Connecticut, and colleagues evaluated trends in racial and ethnic differences in utilization of guideline-recommended pharmacological medications and lifestyle modifications among U.S. adults with ASCVD. Analysis included data from 5,218 participants in the Health and Nutrition Examination Survey (1999 to 2020) with ASCVD.

The researchers found that over the study period, there was a significant increase in total cholesterol control and statin use in all racial and ethnic subgroups. Additionally, there were significant increases seen in angiotensin-converting enzyme inhibitor and angiotensin receptor blocker use among non-Hispanic White and Hispanic and Latino individuals (Hispanic and Latino individuals: 17.12 percentage points; non-Hispanic White individuals: 12.14 percentage points). Smoking cessation increased significantly within the Hispanic and Latino population (−27.13 percentage points), as well as a lessening of the gap in smoking cessation between Hispanic and Latino individuals and White individuals (−24.85 percentage points). From 2017 to 2020, optimal regimens were used in 47.4 percent of Black, 48.7 percent of Hispanic and Latino, and 53.0 percent of White individuals.

"These results suggest that, despite efforts to enhance the quality of care for ASCVD patients, substantial disparities persist between current care and optimal care, underscoring the urgent need for ongoing initiatives to bridge these gaps and improve outcomes for all patients, regardless of their backgrounds," the authors write.

Several authors disclosed ties to the pharmaceutical and medical industries.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-12-06 04:37

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords